Context
Recently, the U.S. Food and Drug Administration approved two treatments namely, Casgevy and Lyfgenia, for the treatment of sickle cell disease (SCD) in patients.
About
About the information:
How these treatments work?
Sickle Cell Disease:
The US Food and Drug Administration (FDA)
|
Verifying, please be patient.